Prelude Therapeutics, Inc. (PRLD)
2.836
-0.10
(-3.54%)
USD |
NASDAQ |
Dec 30, 16:00
2.79
-0.05
(-1.62%)
After-Hours: 20:00
Prelude Therapeutics Total Liabilities (Quarterly): 36.22M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Incyte Corp. | 1.679B |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Relay Therapeutics, Inc. | 62.29M |
| ALX Oncology Holdings, Inc. | 37.92M |
| Immunome, Inc. | 35.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.76M |
| Shareholders Equity (Quarterly) | 58.53M |
| Debt to Equity Ratio | 0.305 |
| Current Ratio | 3.207 |
| Net Debt Paydown Yield | 0.09% |